Fresh Connect Breaks Out Four Different Grocery Cards

Why It Matters

The diversified card suite lets health plans and providers prescribe a wider array of nutritious foods, improving patient adherence and health outcomes while scaling the food‑as‑medicine model nationwide.

Key Takeaways

• Fresh Connect expands from one produce card to four specialized cards
• Cards are backed by distinct Approved Product List created with dietitians
• New Companion App shows cardholders real‑time eligibility for purchases
• Program has delivered $12.3 M in produce to 23,000 users across 15 states
• Grocery Rx targets patients with diet‑related disease using stricter nutrition standards

Pulse Analysis

The food‑as‑medicine movement has moved from pilot projects to a mainstream health‑care strategy, and payment infrastructure is the linchpin. Fresh Connect’s original produce‑only card proved that prepaid debit solutions could channel millions of dollars into healthier diets, reducing chronic‑disease risk for vulnerable populations. By adding a Companion App that flags eligible items at checkout, the company tackles a common barrier—uncertainty about what qualifies—thereby boosting utilization and patient confidence.

The four new cards each operate under a separate Approved Product List (APL), a curated catalog of items vetted by registered dietitians, nutrition scientists and community partners. Produce focuses on fresh fruits and vegetables, while Produce+ adds frozen, additive‑free options. The broader Grocery card opens most aisles to items meeting baseline nutrition standards, and Grocery Rx delivers a medically tailored selection for individuals with diet‑related conditions such as diabetes or hypertension. This tiered approach lets health plans customize prescriptions to clinical severity, aligning spending with evidence‑based dietary guidelines and supporting measurable health outcomes.

For insurers, providers and employers, Fresh Connect’s expanded suite offers a scalable way to integrate nutrition benefits into benefit designs. The ability to target specific disease cohorts with stricter standards could lower long‑term medical costs, while the flexible, technology‑driven platform positions the company to capture a growing share of the $30‑plus billion U.S. food‑as‑medicine market. As more payers adopt value‑based care models, solutions that combine clinical rigor with shopper‑friendly tools are likely to become a competitive differentiator, driving further investment in nutrition‑focused financial products.